|
| 36792016 | Qualitative Study on Diversity, Equity, and Inclusion Within Radiation Oncology in Europe. | Int J Radiat Oncol Biol Phys | 2023 |
| 37947521 | Development of a CRISPR-Cas12a system for efficient genome engineering in clostridia. | Microbiol Spectr | 2023 |
| 37218518 | Clostridia as live biotherapeutics: can modified <i>Clostridium</i> species enhance disease treatments? | Future Microbiol | 2023 |
| 37315579 | Overcoming radioresistance with the hypoxia-activated prodrug CP-506: A pre-clinical study of local tumour control probability. | Radiother Oncol | 2023 |
| 37385265 | A deep-learning assisted bioluminescence tomography method to enable radiation targeting in rat glioblastoma. | Phys Med Biol | 2023 |
| 37211565 | Treating colorectal peritoneal metastases with an injectable cytostatic loaded supramolecular hydrogel in a rodent animal model. | Clin Exp Metastasis | 2023 |
| 37173877 | Polyphenols as Potential Protectors against Radiation-Induced Adverse Effects in Patients with Thoracic Cancer. | Cancers (Basel) | 2023 |
| 37367472 | Predicting the Tumour Response to Radiation by Modelling the Five Rs of Radiotherapy Using PET Images. | J Imaging | 2023 |
| 36754020 | Sodium perturbs mitochondrial respiration and induces dysfunctional Tregs. | Cell Metab | 2023 |
| 36584393 | Roadmap for precision preclinical x-ray radiation studies. | Phys Med Biol | 2023 |
| 36835181 | Use of 3D Spheroid Models for the Assessment of RT Response in Head and Neck Cancer. | Int J Mol Sci | 2023 |
| 36830818 | The Modulatory Effects of Fatty Acids on Cancer Progression. | Biomedicines | 2023 |
| 34241566 | Hypoxia-activated prodrug derivatives of anti-cancer drugs: a patent review 2006 - 2021. | Expert Opin Ther Pat | 2022 |
| 35496817 | A scoping review of small animal image-guided radiotherapy research: Advances, impact and future opportunities in translational radiobiology. | Clin Transl Radiat Oncol | 2022 |
| 35461952 | Establishing a benchmark of diversity, equity, inclusion and workforce engagement in radiation oncology in Europe - An ESTRO collaborative project. | Radiother Oncol | 2022 |
| 35391764 | Deep Learning-based Automatic Lung Segmentation on Multiresolution CT Scans from Healthy and Fibrotic Lungs in Mice. | Radiol Artif Intell | 2022 |
| 35714611 | A deep learning and Monte Carlo based framework for bioluminescence imaging center of mass-guided glioblastoma targeting. | Phys Med Biol | 2022 |
| 35811951 | Fatty Acids as a Tool to Boost Cancer Immunotherapy Efficacy. | Front Nutr | 2022 |
| 35413180 | 'On the Spot' Digital Pathology of Breast Cancer Based on Single-Cell Mass Spectrometry Imaging. | Anal Chem | 2022 |
| 36271018 | Picomolar fluorescent probes for compound affinity determination to carbonic anhydrase IX expressed in live cancer cells. | Sci Rep | 2022 |
| 35988775 | Commentary on the article: Sørensen BS et al., Pencil beam scanning proton FLASH maintains tumor control while normal tissue damage is reduced in a mouse model. | Radiother Oncol | 2022 |
| 36186923 | An impact model to understand and improve work-life balance in early-career researchers in radiation oncology. | Clin Transl Radiat Oncol | 2022 |
| 36077694 | Homologous Recombination Deficiency Scar: Mutations and Beyond-Implications for Precision Oncology. | Cancers (Basel) | 2022 |
| 33558701 | Use of an optimised enzyme/prodrug combination for Clostridia directed enzyme prodrug therapy induces a significant growth delay in necrotic tumours. | Cancer Gene Ther | 2022 |
| 35061600 | Automatic contouring of normal tissues with deep learning for preclinical radiation studies. | Phys Med Biol | 2022 |
| 35111981 | Inter-observer variability of organ contouring for preclinical studies with cone beam Computed Tomography imaging. | Phys Imaging Radiat Oncol | 2022 |
| 35050609 | In Vivo Identification of Adducts from the New Hypoxia-Activated Prodrug CP-506 Using DNA Adductomics. | Chem Res Toxicol | 2022 |
| 33138744 | Experimental Approaches to Identify Selective Picomolar Inhibitors for Carbonic Anhydrase IX. | Curr Med Chem | 2021 |
| 33806808 | Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy. | Cancers (Basel) | 2021 |
| 33688020 | Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapy. | J Immunother Cancer | 2021 |
| 33577864 | Alexithymia and professional quality of life in radiation oncology: The moderator effect of the professional profile. | Radiother Oncol | 2021 |
| 34859607 | Secretion of pro-angiogenic extracellular vesicles during hypoxia is dependent on the autophagy-related protein GABARAPL1. | J Extracell Vesicles | 2021 |
| 34625504 | Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506. | Mol Cancer Ther | 2021 |
| 34041023 | Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio. | Front Oncol | 2021 |
| 34116702 | Mass spectrometry imaging of L-[ring-<sup>13</sup>C<sub>6</sub>]-labeled phenylalanine and tyrosine kinetics in non-small cell lung carcinoma. | Cancer Metab | 2021 |
| 34168629 | Efficient Secretion of Murine IL-2 From an Attenuated Strain of <i>Clostridium sporogenes</i>, a Novel Delivery Vehicle for Cancer Immunotherapy. | Front Microbiol | 2021 |
| 33285270 | Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study. | Int J Radiat Oncol Biol Phys | 2021 |
| 33432108 | The hypoxia-sensor carbonic anhydrase IX affects macrophage metabolism, but is not a suitable biomarker for human cardiovascular disease. | Sci Rep | 2021 |
| 32509579 | Mitochondrial Dysfunction Inhibits Hypoxia-Induced HIF-1α Stabilization and Expression of Its Downstream Targets. | Front Oncol | 2020 |
| 31687859 | Design, synthesis, <i>in vitro</i> inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series. | J Enzyme Inhib Med Chem | 2020 |
| 33194319 | Immunotherapy as sensitizer for local radiotherapy. | Oncoimmunology | 2020 |
| 33137396 | Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiomic signatures. | Radiother Oncol | 2020 |
| 33068606 | A novel co-culture assay to assess anti-tumor CD8<sup>+</sup> T cell cytotoxicity via luminescence and multicolor flow cytometry. | J Immunol Methods | 2020 |
| 33293576 | Mild hyperlipidemia in mice aggravates platelet responsiveness in thrombus formation and exploration of platelet proteome and lipidome. | Sci Rep | 2020 |
| 32745136 | Combining hypoxia-activated prodrugs and radiotherapy in silico: Impact of treatment scheduling and the intra-tumoural oxygen landscape. | PLoS Comput Biol | 2020 |
| 32632379 | Conducting research in Radiation Oncology remotely during the COVID-19 pandemic: Coping with isolation. | Clin Transl Radiat Oncol | 2020 |
| 32929365 | <i>E. coli</i> nitroreductase NfsA is a reporter gene for non-invasive PET imaging in cancer gene therapy applications. | Theranostics | 2020 |
| 32904144 | The role of alexithymia and empathy on radiation therapists' professional quality of life. | Tech Innov Patient Support Radiat Oncol | 2020 |
| 32443462 | Hypoxia-Activated Prodrug Derivatives of Carbonic Anhydrase Inhibitors in Benzenesulfonamide Series: Synthesis and Biological Evaluation. | Molecules | 2020 |
| 32386436 | Human fibronectin extra domain B as a biomarker for targeted therapy in cancer. | Mol Oncol | 2020 |